Vincent P. Laudone, MD


Chief of Surgery, Josie Robertson Surgery Center

Conditions Treated

Vincent P. Laudone, MD -- Co-Director for Robotic Surgery
Media arrow iconAn icon showing a arrow pointing left, indicating being able to play some kind of media.
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a board-certified urologic surgeon who specializes in robotic surgery for people with cancers of the genitourinary system, especially prostate cancer. I’m also Chief of Surgery at MSK’s new Josie Robertson Surgery Center, a pioneering outpatient and short-stay cancer surgery facility located on York Avenue in Manhattan.

In my personal practice, I see approximately 350 to 400 new prostate cancer patients each year and operate on approximately 250 men annually. I’m in my 28th year of doing cancer surgery exclusively and have more than 12 years of experience with robot-assisted surgery.

Throughout these years, my focus has been to optimize the use of this technology and to ensure that we achieve the very best results for each and every patient. In the case of prostate cancer, this means treating the cancer in the most effective way possible while preserving urinary and sexual function to the maximum extent possible.

We’ve entered the age of what I like to call “technologically enhanced surgery.” The major advance of the past decade has been the introduction of the surgical robot. Going forward, my focus is to further develop technology that will enhance what we see — and therefore what we’re able to do — during surgery.

For example, I’m working with my colleagues on a method to take a three-dimensional rendering of a patient’s prostate MRI and bring it into the surgeon’s visual field as he or she operates. This means that surgeons will have right in front of them a real-time view of the surgical anatomy as well as a detailed MRI as a guide.

Another example of my work involves research to develop an agent that can be given to patients prior to surgery that uses laser light to enhance visualization of nerves to avoid nerve injury during surgery.

No single treatment strategy is right for every man. A treatment decision needs to be based on the extent of the disease and the aggressiveness of the cancer, as well as the age, overall health, and quality of life considerations of the patient and his partner. Some men do very well with what we call active surveillance (sometimes called watchful waiting), meaning that no treatment is needed immediately and we carefully monitor the cancer for any indication that it’s growing or becoming more aggressive. Other men require treatment.

But no patient should ever feel rushed or pressured into making a hasty decision. It’s vital to get information and expert opinions. I also believe it’s important to involve your family — especially your partner, if you have one — in the process so that they too can help gather information, evaluate your options, and support your decision before, during, and after treatment.

Finally, my greatest satisfaction comes in getting to know my patients and their families — learning about what’s important to them and assisting them in making the best possible decisions regarding their cancer care. I want to make certain that whatever decision they arrive at, it will serve them well in the immediate term and for the rest of their lives.

  • Clinical Expertise: Robotic Surgery; Prostate Cancer; Bladder Cancer
  • Awards and Honors: Member, Alpha Omega Alpha Medical Society; American Cancer Society Clinical Fellow; Best Doctors in America (2001 – 2011); Top Doctors in Connecticut (2005 – 2011)
  • Languages Spoken: English
  • Education: MD, Georgetown University
  • Residencies: General Surgery - University of Virginia Hospital; Urology - University of Virginia Hospital
  • Fellowships: Urology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Urology

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.